>>Signaling Pathways>> Others>>TH5487

TH5487

Catalog No.GC37776

TH5487은 IC50이 342nM인 강력한 8-옥소구아닌 DNA 글리코실라제 1(OGG1) 억제제입니다.

Products are for research use only. Not for human use. We do not sell to patients.

TH5487 Chemical Structure

Cas No.: 2304947-71-3

Size 가격 재고 수량
5mg
US$109.00
재고 있음
10mg
US$185.00
재고 있음
50mg
US$649.00
재고 있음
100mg
US$1,205.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

TH5487 is a potent 8-oxoguanine DNA glycosylase 1 (OGG1) inhibitor with an IC50 of 342 nM. TH5487 stops OGG1 from recognizing its DNA substrate, inhibits DNA repair and modifies OGG1 chromatin dynamics, which results in the inhibition of proinflammatory pathway genes[1].

TH5487 (5 μM; 1 hour) decreases TNFα- and LPS-induced proinflammatory gene expression to near pretreatment levels[1].TH5487 (0-10 μM; 1 hour) perturbs binding of NF-κB to 8-oxoG-containing synthetic DNA in nuclear extracts from MLE 12 or hSAEC cells[1]. RT-PCR[1] Cell Line: Murine airway epithelial cell line (MLE 12); Diploid human small-airway epithelial cell (hSAECs)

TH5487 (prophylactic intraperitoneally injection; 8-30 mg/kg; 1-9 hours) decreases TNFα or LPS induced the robust recruitment of neutrophils to the airways, and reduces the pulmonary neutrophil count in a time-dependent manner[1]. Animal Model: Eightweek-old female and male BALB/c mice[1]

[1]. Visnes T, et al. Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation. Science. 2018 Nov 16;362(6416):834-839.

리뷰

Review for TH5487

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for TH5487

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.